Asmaa Hachim

1.0k total citations · 1 hit paper
13 papers, 425 citations indexed

About

Asmaa Hachim is a scholar working on Infectious Diseases, Immunology and Epidemiology. According to data from OpenAlex, Asmaa Hachim has authored 13 papers receiving a total of 425 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 5 papers in Immunology and 4 papers in Epidemiology. Recurrent topics in Asmaa Hachim's work include SARS-CoV-2 and COVID-19 Research (9 papers), COVID-19 Clinical Research Studies (7 papers) and Influenza Virus Research Studies (4 papers). Asmaa Hachim is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (9 papers), COVID-19 Clinical Research Studies (7 papers) and Influenza Virus Research Studies (4 papers). Asmaa Hachim collaborates with scholars based in Hong Kong, France and United States. Asmaa Hachim's co-authors include Sophie A. Valkenburg, Niloufar Kavian, Malik Peiris, Leo L. M. Poon, Carolyn A. Cohen, Owen TY Tsang, Alex W. H. Chin, Chris Mok, Ranawaka A. P. M. Perera and David S.C. Hui and has published in prestigious journals such as Nature Medicine, Nature Communications and Nature Immunology.

In The Last Decade

Asmaa Hachim

12 papers receiving 417 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Real-world COVID-19 vaccine effectiveness against the Omicron BA.2 variant in a SARS-CoV-2 infection-naive population

2023 116 citations Samuel M. S. Cheng, Kathy Leung et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Asmaa Hachim Hong Kong	9	347	66	64	63	49	13	425
Christina Capuano United States	5	394 1.1×	53 0.8×	48 0.8×	89 1.4×	29 0.6×	7	487
Catherine Jacob-Dolan United States	10	434 1.3×	121 1.8×	116 1.8×	53 0.8×	68 1.4×	16	532
Abishek Chandrashekar United States	8	365 1.1×	77 1.2×	138 2.2×	51 0.8×	32 0.7×	14	454
Gabriele Anichini Italy	11	300 0.9×	58 0.9×	88 1.4×	59 0.9×	41 0.8×	27	377
Stefania Dispinseri Italy	7	286 0.8×	45 0.7×	66 1.0×	42 0.7×	28 0.6×	13	368
Yexin Yang United States	3	307 0.9×	64 1.0×	68 1.1×	29 0.5×	29 0.6×	4	384
Rosa Isela Gálvez United States	5	311 0.9×	95 1.4×	133 2.1×	45 0.7×	40 0.8×	13	409
Alexis C. R. Hoste United Kingdom	6	446 1.3×	64 1.0×	41 0.6×	50 0.8×	44 0.9×	7	523
Inesa Hyseni Italy	6	488 1.4×	124 1.9×	58 0.9×	33 0.5×	66 1.3×	6	554
Deleah Pettie United States	5	562 1.6×	134 2.0×	78 1.2×	52 0.8×	82 1.7×	5	654

Countries citing papers authored by Asmaa Hachim

Since Specialization

Citations

This map shows the geographic impact of Asmaa Hachim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Asmaa Hachim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Asmaa Hachim more than expected).

Fields of papers citing papers by Asmaa Hachim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Asmaa Hachim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Asmaa Hachim. The network helps show where Asmaa Hachim may publish in the future.

Co-authorship network of co-authors of Asmaa Hachim

This figure shows the co-authorship network connecting the top 25 collaborators of Asmaa Hachim. A scholar is included among the top collaborators of Asmaa Hachim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Asmaa Hachim. Asmaa Hachim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Cheng, Samuel M. S., Kathy Leung, Cheuk Kwong Lee, et al.. (2023). Real-world COVID-19 vaccine effectiveness against the Omicron BA.2 variant in a SARS-CoV-2 infection-naive population. Nature Medicine. 29(2). 348–357. 116 indexed citations breakdown →

Cheng, Samuel M. S., Kathy Leung, Cheuk Kwong Lee, et al.. (2023). Serological assays for differentiating natural COVID-19 infection from vaccine induced immunity. Journal of Clinical Virology. 170. 105621–105621. 3 indexed citations

Teo, Qi Wen, Ho Him Wong, Tiaan Heunis, et al.. (2023). Usp25-Erlin1/2 activity limits cholesterol flux to restrict virus infection. Developmental Cell. 58(22). 2495–2509.e6. 12 indexed citations

Hachim, Asmaa, Haogao Gu, Otared Kavian, et al.. (2022). SARS-CoV-2 accessory proteins reveal distinct serological signatures in children. Nature Communications. 13(1). 2951–2951. 17 indexed citations

Hachim, Asmaa, Niloufar Kavian, & Sophie A. Valkenburg. (2021). Antibody landscapes of SARS-CoV-2 can reveal novel vaccine and diagnostic targets. Current Opinion in Virology. 50. 139–146. 5 indexed citations

Nguyen, Thi H. O., Carolyn A. Cohen, Louise C. Rowntree, et al.. (2021). T Cells Targeting SARS-CoV-2: By Infection, Vaccination, and Against Future Variants. Frontiers in Medicine. 8. 793102–793102. 14 indexed citations

Wu, Chao, Abraham J. Qavi, Austin B. Moyle, et al.. (2021). Domain-specific biochemical and serological characterization of SARS-CoV-2 nucleocapsid protein. STAR Protocols. 2(4). 100906–100906. 2 indexed citations

Cohen, Carolyn A., Asmaa Hachim, David S.C. Hui, et al.. (2021). SARS-CoV-2 specific T cell responses are lower in children and increase with age and time after infection. Nature Communications. 12(1). 4678–4678. 76 indexed citations

Valkenburg, Sophie A., Samuel M. S. Cheng, Asmaa Hachim, Malik Peiris, & John M. Nicholls. (2021). Postmortem Stability of SARS-CoV-2 in Mouse Lung Tissue. Emerging infectious diseases. 27(12). 3173–3175.

10.

Kavian, Niloufar, Asmaa Hachim, Benjamin J. Cowling, & Sophie A. Valkenburg. (2021). Repeated influenza vaccination provides cumulative protection from distinct H3N2 viruses. Clinical & Translational Immunology. 10(6). e1297–e1297. 8 indexed citations

11.

Kavian, Niloufar, Asmaa Hachim, Carolyn A. Cohen, et al.. (2020). Assessment of enhanced influenza vaccination finds that FluAd conveys an advantage in mice and older adults. Clinical & Translational Immunology. 9(2). e1107–e1107. 16 indexed citations

12.

Kavian, Niloufar, Asmaa Hachim, Leo L. M. Poon, & Sophie A. Valkenburg. (2020). Vaccination with ADCC activating HA peptide epitopes provides partial protection from influenza infection. Vaccine. 38(37). 5885–5890. 8 indexed citations

13.

Hachim, Asmaa, Niloufar Kavian, Carolyn A. Cohen, et al.. (2020). ORF8 and ORF3b antibodies are accurate serological markers of early and late SARS-CoV-2 infection. Nature Immunology. 21(10). 1293–1301. 148 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact